XERIS PHARMACEUTICALS INC (31) | Supply Agreements (3)
- Amendment 2 to the Commercial Supply Agreement, dated as of May 13, 2021, by and between Pyramid Laboratories Inc. and the Registrant (Filed With SEC on August 5, 2021)
- First Amendment to API Supply Agreement (Filed With SEC on May 13, 2021)
- First Amendment to the Product Supply Agreement, dated as of June 24, 2020, by and between the Company and SHL Pharma LLC (Filed With SEC on August 10, 2020)
